Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
palovarotene, Quantity: 2.5 mg
Ipsen Pty Ltd
Capsule, hard
Excipient Ingredients: croscarmellose sodium; lactose monohydrate; povidone; magnesium stearate; microcrystalline cellulose; sodium lauryl sulfate; titanium dioxide; potable water; Gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; Shellac; ethanol absolute; iron oxide black; ammonia; potassium hydroxide
Oral
28 hard capsules
(S4) Prescription Only Medicine
SOHONOS is indicated to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva (FOP).
Visual Identification: Size 0 hard gelatin capsules with opaque white body and cap, imprinted with "PVO 2.5" on each side of the capsule body in black ink; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Registered